FDA official logo
GSRS logoPFDA official logo

CANVUPARATIDE HYDROCHLORIDE

UNII:KAY8L78E2G
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:CANVUPARATIDE HYDROCHLORIDE
GSRS Full Record:
KAY8L78E2G
i

  • 2935491-32-8
  • 1-32-Human parathydroid hormone, N-[N<sup>6</sup>-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-γ-glutamyl]-D-lysyl-N-methylglycyl]-32a-[N<sup>6</sup>-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-γ-glutamyl]-L-lysine], hydrochloride (1:9)
  • CANVUPARATIDE HYDROCHLORIDE [USAN]
  • Canvuparatide hydrochloride
  • Human parathyroid hormone (PTH) peptide fragment (1-32), N32-amide substituted at N2.1 with N6-[N-(17-{[N-(17-carboxyheptadecanoyl)-L-γ-glutamyl]amino}-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oyl)-L-γ-glutamyl]-D-lysyl-N-methylglycyl and at N1.32 with [(1S)-5-{[N-(17-{[N-(17-carboxyheptadecanoyl)-L-γ-glutamyl]amino}-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oyl)-L-γ-glutamyl]amino}-1-carboxypentyl groups; N6-[N-(17-{[N-(17-carboxyheptadecanoyl)-L-γ-glutamyl]amino}-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oyl)-L-γ-glutamyl]-L-lysyl-N-methylglycyl-L-seryl-L-valyl-L-seryl-L-αglutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-Lleucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-α-glutamyl-Larginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-Lglutaminyl-L-α-aspartyl-L-valyl-L-histidyl-N6-[N-(17-{[N-(17-carboxyheptadecanoyl)-L-γglutamyl]amino}-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oyl)-L-γ-glutamyl]-L-lysine nonahydrochloride
  • MBX 2109 HCl




UNII - KAY8L78E2G | UNII Search Service